New consensus paper recommends “treat-to-target” strategy

Giant cell arteritis and polymyalgia rheumatica are inflammatory rheumatic diseases that often occur together and almost exclusively affect people over the age of 50. Glucocorticoids are initially used for both clinical pictures, whereby the steroid dose should be reduced over the course of the disease in order to counteract the negative consequences of long-term use. As part of steroid-sparing therapy, immunosuppressants and biologics have proven their worth as add-ons.